Allende & Brea, Nader, Hayaux & Goebel and DLA Piper advised on the deal
ARJ is based in Mexico City, Mexico and is the largest private pharmaceutical testing laboratory in Latin America with revenues of over $30 million. Founded in 1967 and employing over 500 people, ARJ specialises in providing quality control for medicines, biological products, generics, biosimilars, cosmetics and medical devices and services many of the largest global pharmaceutical companies.
Mexico is a growing part of the $20 billion global pharmaceutical testing market and an important hub for Latin and North America. ARJ will complement the existing ALS Life Sciences Latin America operations and is expected to benefit from Group’s regional and global presence to further expand their offering to clients.
ALS is a global testing, inspection and certification business. The company’s strategy is to broaden its exposure into new sectors and geographies where it can take a leadership position.
Allende & Brea advised ALS Global with Raúl Fratantoni (Picture) Pedro Echavarría Coll and Alfonsina Bronzovich Canga.
In Mexico, Nader, Hayaux & Goebel advised ALS Global with Diego Sánchez V., Alejandro Alfonso G, Miguel Ángel González J., Rainer Walz del Valle, Galia Slodownik W. and Vanessa Ocampo M.
DLA Piper advised Laboratorio de Control ARJ, S.A. de C.V. with Xavier Mangino Dueñas and Manuel Hallivis.
Involved fees earner: Alfonsina Bronzovich Canga – Allende & Brea Abogados; Pedro Echavarría Coll – Allende & Brea Abogados; Raúl Fratantoni – Allende & Brea Abogados; Manuel Hallivis – DLA Piper; Xavier Mangino – DLA Piper; Alejandro Alfonso G. – Nader, Hayaux & Goebel; Miguel Angel González – Nader, Hayaux & Goebel; Diego Sánchez Villarreal – Nader, Hayaux & Goebel; Rainer Walz del Valle – Nader, Hayaux & Goebel;